CAPITOL COUNSEL LLC

Lobbying for ZAI LAB (US) LLC · Commercial stage biopharmaceutical company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $50,000.00 income · posted Oct 16, 2025

Lobbying activity 2

Financial Institutions/Investments/Securities

Issues regarding drug manufacturing supply chains, health care and financial services impacting the biotechnology and pharmaceutical industry.

Health Issues

Issues regarding drug manufacturing supply chains, health care and financial services impacting the biotechnology and pharmaceutical industry.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.